Related Experiment Video
Updated: Mar 30, 2026

08:48
A Rat Model of EcoHIV Brain Infection
Published on: January 21, 2021
3.9K
Gene Expression in HIV-Associated Neurocognitive Disorders: A Meta-Analysis
Umaporn Siangphoe1, Kellie J Archer
1Department of Biostatistics, Virginia Commonwealth University, Richmond, VA.
Journal of Acquired Immune Deficiency Syndromes (1999)
|November 17, 2015
Summary
This study identified 94 differentially expressed genes in the white matter of HIV-associated neurocognitive disorders (HAND) patients, highlighting immune system pathways. The meta-analysis improved the power to detect these key genes in HAND.
Area of Science:
- Neuroscience
- Genetics
- Immunology
Background:
- HIV-associated neurocognitive disorders (HAND) represent a significant neurological complication of HIV infection.
- Identifying specific gene expression changes in the brain is crucial for understanding HAND pathogenesis.
Purpose of the Study:
- To identify differentially expressed (DE) genes in the brain tissue of patients with HAND compared to HIV-infected individuals without HAND and controls.
- To leverage a meta-analytic approach to increase statistical power in detecting DE genes.
Main Methods:
- A meta-analysis of publicly available gene expression data from three postmortem brain tissue studies.
- Inclusion criteria were clearly defined, and data preprocessing was performed for each brain region.
- Meta-analytic methods included combining P values and effect sizes; DE genes were defined using a false discovery rate < 5%.
Main Results:
- The meta-analysis included 48 postmortem brains (25 HAND, 7 HIV encephalitis, 8 HIV-infected, 8 controls).
- 411 genes were differentially expressed in white matter of HAND with HIV encephalitis patients versus controls; 94 were significant across all methods.
- These 94 genes are involved in immune system, interferon response, and antigen presentation pathways, with 66 upregulated.
Conclusions:
- A meta-analytic approach identified DE genes not found in individual studies, demonstrating increased statistical power.
- The identified genes provide insights into the molecular mechanisms underlying HAND.
Related Concept Videos
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Drugs Affecting Neurotransmitter Synthesis
2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Biological Causes of Schizophrenia
1.1K
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
1.1K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Human Genetics
1.9K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K

